Miyazono K - Search Results

1

Casein kinase 2-interacting protein-1, a novel Akt pleckstrin homology domain-interacting protein, down-regulates PI3K/Akt signaling and suppresses tumor growth in vivo.

Tokuda E, Fujita N, Oh-hara T, Sato S, Kurata A, Katayama R, Itoh T, Takenawa T, Miyazono K, Tsuruo T. Tokuda E, et al. Among authors: miyazono k. Cancer Res. 2007 Oct 15;67(20):9666-76. doi: 10.1158/0008-5472.CAN-07-1050. Cancer Res. 2007. PMID: 17942896

2

ASK1 mediates apoptotic cell death induced by genotoxic stress.

Chen Z, Seimiya H, Naito M, Mashima T, Kizaki A, Dan S, Imaizumi M, Ichijo H, Miyazono K, Tsuruo T. Chen Z, et al. Among authors: miyazono k. Oncogene. 1999 Jan 7;18(1):173-80. doi: 10.1038/sj.onc.1202276. Oncogene. 1999. PMID: 9926932

3

Positive and negative regulation of TGF-beta signaling.

Miyazono K. Miyazono K. J Cell Sci. 2000 Apr;113 ( Pt 7):1101-9. doi: 10.1242/jcs.113.7.1101. J Cell Sci. 2000. PMID: 10704361 Review.

4

TGF-beta signaling by Smad proteins.

Miyazono K, ten Dijke P, Heldin CH. Miyazono K, et al. Adv Immunol. 2000;75:115-57. doi: 10.1016/s0065-2776(00)75003-6. Adv Immunol. 2000. PMID: 10879283 Review.

5

TGF-beta/SMAD signaling and its involvement in tumor progression.

Miyazono K. Miyazono K. Biol Pharm Bull. 2000 Oct;23(10):1125-30. doi: 10.1248/bpb.23.1125. Biol Pharm Bull. 2000. PMID: 11041237 Free article. Review.

6

The N domain of Smad7 is essential for specific inhibition of transforming growth factor-beta signaling.

Hanyu A, Ishidou Y, Ebisawa T, Shimanuki T, Imamura T, Miyazono K. Hanyu A, et al. Among authors: miyazono k. J Cell Biol. 2001 Dec 10;155(6):1017-27. doi: 10.1083/jcb.200106023. Epub 2001 Dec 10. J Cell Biol. 2001. PMID: 11739411 Free PMC article.

7

Compound disruption of smad2 accelerates malignant progression of intestinal tumors in apc knockout mice.

Hamamoto T, Beppu H, Okada H, Kawabata M, Kitamura T, Miyazono K, Kato M. Hamamoto T, et al. Among authors: miyazono k. Cancer Res. 2002 Oct 15;62(20):5955-61. Cancer Res. 2002. PMID: 12384562

8

Lymphoid enhancer factor 1 makes cells resistant to transforming growth factor beta-induced repression of c-myc.

Sasaki T, Suzuki H, Yagi K, Furuhashi M, Yao R, Susa S, Noda T, Arai Y, Miyazono K, Kato M. Sasaki T, et al. Among authors: miyazono k. Cancer Res. 2003 Feb 15;63(4):801-6. Cancer Res. 2003. PMID: 12591729

9

SB-431542 and Gleevec inhibit transforming growth factor-beta-induced proliferation of human osteosarcoma cells.

Matsuyama S, Iwadate M, Kondo M, Saitoh M, Hanyu A, Shimizu K, Aburatani H, Mishima HK, Imamura T, Miyazono K, Miyazawa K. Matsuyama S, et al. Among authors: miyazono k. Cancer Res. 2003 Nov 15;63(22):7791-8. Cancer Res. 2003. PMID: 14633705

10

Transforming growth factor-beta signaling is differentially inhibited by Smad2D450E and Smad3D407E.

Kondo M, Suzuki H, Takehara K, Miyazono K, Kato M. Kondo M, et al. Among authors: miyazono k. Cancer Sci. 2004 Jan;95(1):12-7. doi: 10.1111/j.1349-7006.2004.tb03164.x. Cancer Sci. 2004. PMID: 14720321 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

596 results

Search Page

Filters